Ocular Hypertension
📧 Sign up to get email alerts when something new happens for Ocular Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2011-09-07FDA Approved: TRAVATAN Z — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for TRAVATAN Z (travoprost) submitted by Novartis Pharmaceuticals, updating the product labeling…
-
CLINICAL_TRIALS trial_result · 2011-09-05Clinical Trial Update: A Study to Evaluate Efficacy and Safety Effects Using Mikelan® LA Ophthalmic Solution (OS) 2% Versus Timoptol® XE Ophthalmic Solution (OS) 0.5% in Ocular Hypertension Patients [Phase 4]
Phase 4 study comparing Mikelan LA ophthalmic solution 2% to Timoptol XE ophthalmic solution 0.5% in patients with glaucoma/ocular hypertens…
-
CLINICAL_TRIALS trial_result · 2011-08-18Clinical Trial Update: The Response of Intraocular Pressure to Systemic Hypercapnia and Hyperoxia
A clinical trial update investigating how intraocular pressure responds to systemic hypercapnia and hyperoxia.
-
CLINICAL_TRIALS trial_result · 2011-07-21Clinical Trial Update: Exploratory Study Comparing Signs and Symptoms in Patients With Ocular Hypertension or Glaucoma Using Xalatan R® or Travatan Z® [Phase 4]
Phase 4 exploratory trial comparing signs and symptoms in patients with ocular hypertension or glaucoma treated with Xalatan and Travatan Z.
-
CLINICAL_TRIALS trial_result · 2011-07-14Clinical Trial Update: Assessment of a New Goldmann Applanation Tonometer [Phase 3]
A Phase 3 clinical trial evaluating a new Goldmann Applanation Tonometer for measuring intraocular pressure has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-07-08Clinical Trial Update: A Study of Ganfort Versus Duotrav in Patients With Primary Open Angle Glaucoma or Ocular Hypertension [Phase 3]
A Phase 3 study comparing Ganfort versus Duotrav in patients with primary open-angle glaucoma or ocular hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-23Clinical Trial Update: Travoprost Five Day Posology Study [Phase 2]
Phase 2 clinical trial update evaluating five-day posology of travoprost in open-angle glaucoma and ocular hypertension. The study results w…
-
CLINICAL_TRIALS research · 2011-06-23Clinical Trial Update: Relationship Between Central Corneal Thickness and Intraocular Pressure Measures Instruments.
A completed clinical trial examining how central corneal thickness affects intraocular pressure measurements across different instruments in…
-
CLINICAL_TRIALS trial_result · 2011-05-30Clinical Trial Update: Safety and Efficacy Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension [Phase 2, Phase 3]
Clinical trial update reporting safety and efficacy findings for bimatoprost in patients with glaucoma or ocular hypertension across Phase 2…
-
CLINICAL_TRIALS trial_result · 2011-05-30Clinical Trial Update: Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 clinical trial update evaluating the safety and efficacy of the Brimonidine tartrate/timolol maleate fixed-dose combination in patie…
-
CLINICAL_TRIALS trial_result · 2011-05-30Clinical Trial Update: Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients Wtih Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 trial evaluating the safety and efficacy of the bimatoprost/timolol fixed-dose combination in glaucoma or ocular hypertension has co…
-
CLINICAL_TRIALS trial_result · 2011-05-30Clinical Trial Update: Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 clinical trial assessing the safety and efficacy of Ganfort (bimatoprost/timolol fixed combination) in patients with glaucoma or ocu…
-
CLINICAL_TRIALS trial_result · 2011-05-30Clinical Trial Update: Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension [Phase 2]
A Phase 2 study evaluating the safety and efficacy of the fixed-dose combination of brimonidine tartrate and timolol for glaucoma or ocular …
-
CLINICAL_TRIALS trial_result · 2011-05-30Clinical Trial Update: Safety and Efficacy of Brimonidine in Patients With Glaucoma or Ocular Hypertension [Phase 3]
A Phase 3 trial evaluating the safety and efficacy of Brimonidine in patients with glaucoma or ocular hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-30Clinical Trial Update: Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension [Phase 3]
A Phase 3 clinical trial evaluating the safety and efficacy of a fixed-dose combination of bimatoprost and timolol in patients with glaucoma…
-
CLINICAL_TRIALS trial_result · 2011-05-30Clinical Trial Update: Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 safety and efficacy study of the fixed combination of brimonidine and timolol in glaucoma or ocular hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-27Clinical Trial Update: Effects of Latanoprost, Bimatoprost and Travoprost in Patients With Latanoprost-resistant Glaucoma [NA]
A clinical trial evaluating latanoprost, bimatoprost, and travoprost in latanoprost-resistant glaucoma. The study status is UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2011-03-25Clinical Trial Update: A 6 Month Study Comparing Latanoprost With Timolol in Patients With Open Angle Glaucoma or Ocular Hypertension [Phase 3]
A Phase 3 trial comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension has completed.
-
FDA approval · 2011-03-22FDA Approved: LATANOPROST — Original Application (Bausch & Lomb Incorporated)
FDA approved latanoprost as an original application generic product by Bausch & Lomb Incorporated.
-
FDA approval · 2011-03-22FDA Approved: LATANOPROST — Original Application (Sandoz Inc)
FDA approves the generic latanoprost (Sandoz) under Original Application (ANDA). The product is indicated for reduction of elevated intraocu…
-
FDA approval · 2011-03-22FDA Approved: LATANOPROST — Original Application (Somerset Therapeutics, LLC)
FDA approved the original application for latanoprost from Somerset Therapeutics, enabling a generic latanoprost ophthalmic solution for red…
-
CLINICAL_TRIALS trial_result · 2011-03-18Clinical Trial Update: Central Corneal Thickness With SENSIMED Triggerfish
This clinical trial update notes the completion of a study evaluating central corneal thickness measurements using the SENSIMED Triggerfish …
-
FDA approval · 2011-03-08FDA Approved: BRINZOLAMIDE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for brinzolamide submitted by Sandoz Inc.
-
CLINICAL_TRIALS trial_result · 2011-03-08Clinical Trial Update: Efficacy Study of Travoprost APS Versus TRAVATAN [Phase 3]
Phase 3 efficacy trial comparing Travoprost APS with TRAVATAN in open-angle glaucoma and ocular hypertension; results were posted after comp…
-
FDA approval · 2011-01-28FDA Approved: DORZOLAMIDE HYDROCHLORIDE — Supplemental Application (Advagen Pharma Ltd.)
FDA approved a supplemental application for dorzolamide hydrochloride from Advagen Pharma Ltd., a generic product used to treat open-angle g…